Constitutive expression of EREG is low in normal tissues but elevated in various cancer types, such as non-small cell lung cancer, breast cancer, gastric cancer, head and neck cancer, ovarian cancer, colorectal cancer, brain cancer, bladder cancer, and is thought to promote tumor progression [17,18]. Here, EREG is linked to cancer.